| Product NDC: | 16590-266 |
| Proprietary Name: | CLONIDINE |
| Non Proprietary Name: | CLONIDINE HCL |
| Active Ingredient(s): | .1 mg/1 & nbsp; CLONIDINE HCL |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 16590-266 |
| Labeler Name: | STAT RX USA LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA070974 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19861216 |
| Package NDC: | 16590-266-72 |
| Package Description: | 120 TABLET in 1 BOTTLE, PLASTIC (16590-266-72) |
| NDC Code | 16590-266-72 |
| Proprietary Name | CLONIDINE |
| Package Description | 120 TABLET in 1 BOTTLE, PLASTIC (16590-266-72) |
| Product NDC | 16590-266 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CLONIDINE HCL |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19861216 |
| Marketing Category Name | ANDA |
| Labeler Name | STAT RX USA LLC |
| Substance Name | CLONIDINE HYDROCHLORIDE |
| Strength Number | .1 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |